National Lymphangioleiomyomatosis Registry, France

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorVincent COTTIN

About this trial

RE-LAM-CE is a registry of lymphangioleiomyomatosis cases in France. its aim is to determine the incidence and prevalence of lymphangioleiomyomatosis in France, including demographic information and information concerning the timing and modalities of diagnosis.

Based on the registry, we will set up a prospective cohort of patients. The database will include detailed medical information, particularly regarding progression of the respiratory function.

Eligibility criteria

Qualifiers

Patients with sporadic lymphangioleiomyomatosis or associated with Tuberous sclerosis.

patients diagnosed or hospitalized or seen in consultation since 01/01/2008

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Vincent COTTIN

Lead sponsor

Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires

Sponsor institution

Hospices Civils de Lyon

Collaborator